Amyotrophic lateral sclerosis has always been a disease of contradictions. Two patients of the same age, diagnosed on the same day, with symptoms that began in the same part of the body, can follow ...
In 2007, the England rugby squad took part in a team-building training camp with the Special Forces ahead of the World Cup. At the end, it was Moody who the instructors named “The Ultimate Team-mate.” ...
In a study published in Molecular Therapy Advances a team of researchers led by Professor Haruhisa Inoue (Center for iPS Cell Research and Application, Kyoto University) and Professor Yuishin Izumi ...
A team of researchers led by Professor Haruhisa Inoue (Center for iPS Cell Research and Application, Kyoto University) and Professor Yuishin Izumi (Tokushima University) demonstrated that adenine base ...
A team of researchers led by Professor Haruhisa Inoue (Center for iPS Cell Research and Application, Kyoto University) and Professor Yuishin Izumi (Tokushima University) demonstrated that adenine base ...
The Aussie bowling great made a statement in the first Test against South Africa. Find out more here. The Premier League may have just returned from a three-week break, but for many of its stars there ...
In a mouse model of Huntington’s disease, researchers found that activating vasoactive intestinal peptide (VIP) neurons in the motor cortex promoted motor learning and improved movement. Flavio Coelho ...
Motor neurons, the nerve cells that control muscles, have a reputation as passive messengers. But growing evidence suggests they do more than simply relay the brain’s commands. Work in fruit flies ...
Dr. Wright, who directed the research, said the approach could have major implications for diseases that affect tens of millions of people around the world. "We've made intracellular antibodies that ...
Motor Neurone Disease (MND) is a rare condition that progressively damages parts of the nervous system. Recognizing the signs and symptoms of MND is crucial for early detection and intervention. Here ...
Please provide your email address to receive an email when new articles are posted on . Tavapadon targets D1/D5 receptors without the adverse events seen in other therapies. 4% of the tavapadon group ...